NCT00165867View on ClinicalTrials.gov

An Open Label Phase II Study of Indisulam in Combination With Irinotecan in Patients With Metastatic Colorectal Cancer Who Have Been Previously Treated With 5-Fluorouracil/Leucovorin and Oxaliplatin

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2005

Conditions

Colorectal Cancer

Interventions

DRUG

E7070

Trial Locations (7)

F- 68024

Hôpitaux Civils de Colmar, Colmar

F-34298

CRLC Val d'Aurelle, Montpellier

F-06189

Centre Antoine Lacassagne, Nice

AB25 2ZN

Aberdeen Royal Infirmary, Aberdeen

G11 6NT

Beatson Oncology Centre, Glasgow

LS16 6QB

Cookridge Hospital, Leeds

LE1 5WW

Leicester Royal Infirmary, Leicester

All Listed Sponsors

lead

Eisai Limited

INDUSTRY

NCT00165867 - An Open Label Phase II Study of Indisulam in Combination With Irinotecan in Patients With Metastatic Colorectal Cancer Who Have Been Previously Treated With 5-Fluorouracil/Leucovorin and Oxaliplatin | Biotech Hunter | Biotech Hunter